Lixisenatide Subcutaneous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Lixisenatide Subcutaneous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Pneumococcal 13-valent conjugate vaccine
- Lixisenatide Subcutaneous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Lixisenatide Subcutaneous-Pneumococcal Conjugate Vaccine (13-Valent)
- Lixisenatide Subcutaneous-Pneumococcal Conjugate Vaccine (7-Valent)
- Lixisenatide Subcutaneous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Lixisenatide Subcutaneous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Lixtraxen Injection
- Pms-Sodium Polystyrene Sulfonate-LMD
- Pms-Sodium Polystyrene Sulfonate-LMD Injection
- Pms-Sodium Polystyrene Sulfonate-LMX 4 Topical application
- Pms-Sodium Polystyrene Sulfonate-LMX 5
- Pms-Sodium Polystyrene Sulfonate-LMX 5 Topical application